Risk factors for asthma deaths: A population-based, case-control study

Australian and New Zealand Journal of Public Health

Volumn 23, Issue 6, 1999, Pages 595-600

  Jalaludin, Bin B ^a   Smith, Mark A ^b   Chey, Tien ^b   Orr, Neil J ^b   Smith, Wayne T ^b   Leeder, Stephen R ^b  

^a Epidemiology Unit   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CROMOGLYCATE DISODIUM; IPRATROPIUM BROMIDE; PREDNISONE; STEROID; THEOPHYLLINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CASE CONTROL STUDY; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DRUG USE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; REGRESSION ANALYSIS; RISK FACTOR; SCHOOL CHILD; TELEPHONE;

EID: 0033398032     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.1999.tb01543.x     Document Type: Article

References (21)

1. Jackson RT, Beaglehole R, Rea HH, Sutherland DC. Mortality from asthma: A new epidemic in New Zealand. Br Med J 1982; 285: 771-4.
2. Crane J, Pearce NE, Flatt A, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-1983: case-control study. Lancet 1989; 1: 917-22.
3. Pearce NE, Grainger J, Atkinson M, et al. Case control study of prescribed fenoterol and death from asthma in New Zealand, 1977-1981. Thorax 1990; 46: 105-11.
4. Spitzer WO, Suissa S, Ernst P, et al. The use of beta agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501-6.
5. Grainger J, Woodman K, Pearce N, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-87: A further case-control study. Thorax 1990; 46: 105-11.
6. Garrett JE, Lanes SF, Kolbe J, Rea HH. Risk of severe life-threatening asthma and (ß)-agonist type: An example of confounding by severity. Thorax 1996; 51: 1093-9.
7. Robertson CF, Rubinfield AR, Bowes G. Deaths from asthma in Victoria: A twelve month survey. Med J Aust 1990; 152: 511-7.
8. Sears MR, Rea HH, Beaglehole R, et al Asthma mortality in New Zealand: A two year national study. N Z Med J 1985; 98(777): 271-5.
9. Crane J, Pearce N, Burgess C, et al. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma Int J Epidemiol 1992; 21: 737-44.
10. Kish L. A procedure for objective respondent selection within the household J Am Stat Assoc 1949; 44: 380-7.
11. Australian Bureau of Statistics mortality data and population estimates (HOIST), Epidemiology and Surveillance Branch, New South Wales Health Department, 1978-1995.
12. Rea HH, Scragg R, Jackson R, et al. A case-control study of deaths from asthma. Thorax 1986; 41: 833-9.
13. Rea HH, Garrett JE, Lanes SF, et al. The association between asthma drugs and severe life-threatening attacks. Chest 1996; 110(6): 1446-51.
14. Pearce N, Beasley R, Crane J, et al. End of the New Zealand asthma epidemic mortality. Lancet 1995; 345: 41-4.
15. Turner MO, Noertjojo K, Vedal S, et al. Risk factors for near-fatal asthma. A case-control study in hospitalised patients with asthma. Am J Respir Crit Care Med 1988; 157: 1804-9.
16. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992; 135: 1029-41.
17. Marcus AC, Crane LA. Telephone surveys in public health research. Med Care 1986; 24(2): 97-112.
18. Smith W, Chey T, Jalaludin B, et al. Increasing response rates in telephone surveys: A randomized trial. J Public Health Med 1995; 17(1): 33-8.
19. Taylor AW, Wilson DH, Wakefield M. Differences in health estimates using telephone and door-to-door survey methods - a hypothetical exercise. Aust N Z J Public Health 1998; 22(2): 223-6.
20. Burgess C, Pierce N, Thiruchelvam R, et al. Prescribed drug therapy and nearfatal asthma attacks. Eur Respir J 1994; 7: 498-503.
21. Marquette CH. Saulnier F, LeRoy O, et al. Long-term prognosis of near-fatal asthma. Am Rev Respir Dis 1992; 146: 76-81.